Pune, India, October 6th, 2026, FinanceWire

Austin, Texas, October 6th, 2026, FinanceWire

Quantum BioPharma (NASDAQ: QNTM) entered into a Study Start-Up Agreement (“SUA”) with the clinical research business of Thermo Fisher Scientific to implement its Phase 2 clinical trial of Lucid-21-302 (“Lucid-MS”) for multiple sclerosis (“MS”). The agreement initiates formal study start-up activities following FDA clearance to proceed with the trial. Thermo Fisher will support study start-up […]

Beeline Holdings (NASDAQ: BLNE) provided a preliminary update on third-quarter 2026 performance, expecting revenue to reach the second-highest quarterly level in company history and the highest since 2021, while achieving its highest margins to date. Beeline also expects its net loss to decline from Q2, adjusted EBITDA loss to improve to its lowest level in […]